In a clinical trial, what do we expect the tolerability rate to be among the placebo group?

In a phase II clinical trial that assess the safety and tolerability of an investigational product versus placebo, do we normally consider a tolerability rate for the placebo group? Do we expect...

10 November 2022 1,865 3 View